Abstract
Esophageal cancer is one of the gastrointestinal cancers with the greatest incidence over the past years and is the eighth most common cancer worldwide, affecting more than 450 000 people per year1. Its treatment and prognosis depend on tumor stage, location, histological type, nutritional status and presence of comorbidities2. Although there have been significant advances in the field of oncology in recent years, esophagectomy with lymph node clearance remains the main curative treatment. Total esophagectomy with two-field or three-field lymphadenectomy plays a very important role in the locoregional control of the disease. In recent years, the technological advances and the development of minimally invasive surgical techniques have significantly reduced morbidity and mortality.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
